KR910000481B1 - Process for preparing pyridine derivatives - Google Patents
Process for preparing pyridine derivatives Download PDFInfo
- Publication number
- KR910000481B1 KR910000481B1 KR1019880016395A KR880016395A KR910000481B1 KR 910000481 B1 KR910000481 B1 KR 910000481B1 KR 1019880016395 A KR1019880016395 A KR 1019880016395A KR 880016395 A KR880016395 A KR 880016395A KR 910000481 B1 KR910000481 B1 KR 910000481B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- preparation
- group
- methoxy
- Prior art date
Links
- 0 *C1=C(*)C(*)=C(*)*C1 Chemical compound *C1=C(*)C(*)=C(*)*C1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
Abstract
Description
본 발명은 위궤양 치료제로 유용한 구조식(II)의 벤즈이미다졸 유도체의 합성중간체로 이용되는 구조식(I)의 피리딘 유도체의 신규한 제조방법에 관한 것이다.The present invention relates to a novel process for the preparation of pyridine derivatives of formula (I) for use as a synthetic intermediate of benzimidazole derivatives of formula (II) useful as a therapeutic agent for gastric ulcers.
(여기에서, R은 메톡시기 또는 트리플루오로메틸기이고, n 은 0또는 1인 정수이며, R1과 R2는 각각 수소 또는 메틸기로부터 독립적으로 선택된 것이다.Wherein R is a methoxy group or a trifluoromethyl group, n is an integer of 0 or 1, and R 1 and R 2 are each independently selected from hydrogen or methyl group.
구조식(I)의 화합물중에서 R1및 R2가 메틸기인 구조식(I)'의 2-하이드록시메틸-4-메톡시-3,5-디메틸피리딘 유리염기의 제조방법은 국내 공개특허공보 (공개번호 : 제84-5718호)에 기재된바 있으며, 이를 좀더 구체적으로 설명하면 다음과 같다.Among the compounds of formula (I), a method for preparing 2-hydroxymethyl-4-methoxy-3,5-dimethylpyridine free base of formula (I) 'wherein R 1 and R 2 are methyl groups is disclosed in Korea. No. 84-5718), which will be described in more detail as follows.
첫째, 구조식(III)의 4-메톡시-2,3,5-트리메틸피리딘 N-옥사이드 화합물을 무수초산과 반응시켜 구조식(IV)의 2-아세톡시메틸 피리딘 유도체를 제조한 다음, 이를 가수분해시켜 구조식(I)' 의 화합물을 제조하는 방법.First, a 2-acetoxymethyl pyridine derivative of formula (IV) is prepared by reacting 4-methoxy-2,3,5-trimethylpyridine N-oxide compound of formula (III) with acetic anhydride, and then hydrolyzing it To prepare a compound of formula (I) '.
둘째, 구조식(V)의 4-메톡시-3,5-디메틸피리딘 N-옥사이드 화합물을 디메틸설페이트와 반응시켜 구조식(VI)의 N-메톡시 유도체를 제조한 다음, 이를 유리라디칼화제와 반응시켜 구조식(I)'의 화합물을 제조하는 방법으로 요약된다.Second, the 4-methoxy-3,5-dimethylpyridine N-oxide compound of formula (V) is reacted with dimethyl sulfate to prepare an N-methoxy derivative of formula (VI), which is then reacted with a free radical agent. To a method of preparing the compound of formula (I) '.
본 발명자들의 개발팀은 본 발명의 목적화합물에 대한 신규의 제조방법을 개발하여 특허원 제86-8700로 출원 완료하여 현재 계류중에 있다. 이 방법을 반응식으로 나타내면 다음과 같다.The development team of the present inventors developed a novel manufacturing method for the target compound of the present invention and filed the patent application No. 86-8700 and is currently pending. This method is represented by the following scheme.
그러나 상기 방법은 구조식(나)의 화합물을 과산화수소로 다시 산화시켜서 피리딘 모핵의 N-옥사이드로 전환시켜서 구조식(다)의 화합물을 제조한 후에 니트로기(NO2)를 메톡시기(CH3O)로 치환시킨 후, 다시 N-옥사이드를 환원시켜서 구조식(마)의 화합물을 제조하여야만 되는 번거로운 공정을 거쳐야만 하였다. 또한 이 방법에서는 제1공정 및 제5공정이 개선되지 못하여 전체적인 수율이 약 28% 정도의 낮은 수율에 불과하였다.However, the above method converts the compound of formula (I) into hydrogen peroxide and converts it to N-oxide of the pyridine nucleus to prepare the compound of formula (C), and then converts the nitro group (NO 2 ) to the methoxy group (CH 3 O). After substitution, N-oxide was reduced again to go through a cumbersome process in which the compound of formula (M) had to be prepared. In addition, in this method, the first and fifth processes were not improved, and the overall yield was only a low yield of about 28%.
본 발명자들은 더욱 연구를 행한 결과, 피리딘 모핵의 4-NO2기를 메톡시기(CH3O) 치환시킴에 있어서 피리딘 모핵의 N-옥사이드 화합물을 사용하지 않고도 그 치환이 가능한 놀라운 사실을 발견하였으며, 따라서 N-옥사이드 생성공정 및 4-NO2기를 메톡시기로 치환후의 N-옥사이드 환원공정이 필요없을 뿐만 아니라, 제1공정 및 최종공정인 환원공정도 개선하여 전체적인 수율이 약 67% 이상의 높은 수율로 목적화합물을 제조할 수 있는 새로운 사실을 발견하여 본 발명을 완성하게 되었다.The present inventors have conducted a further study, were in the group of pyridine-4-NO 2 mohaek Sikkim substituted methoxy (CH 3 O) discovered the surprising fact that substitution is possible without the use of a compound of pyridine N- oxide mohaek, thus Not only does the N-oxide generation process and the N-oxide reduction process after replacing 4-NO 2 group with a methoxy group are necessary, but the first and final reduction processes are also improved, so that the overall yield is higher than about 67%. The discovery of new facts on the preparation of compounds has led to the completion of the present invention.
따라서 본 발명의 목적은 새롭고 진보된 방법으로 구조식(I)의 화합물을 제조하는 방법을 제공하는 것이다.It is therefore an object of the present invention to provide a process for the preparation of compounds of formula (I) in new and advanced methods.
본 발명에서는 구조식(VII)의 화합물에 시안기를 도입시켜 구조식(VIII)의 화합물을 제조한 후에 니트로기를 메톡시기로 치환시켜 구조식(IX)의 화합물을 제조한 다음, 염기성 수용액 중에서 가수분해 반응시켜 구조식(X)의 화합물을 제조하고, 이를 메탄올 또는 에탄올과 산촉매하에서 반응시켜 구조식(XI)의 피리딘 카르복실산의 메틸에스테르 또는 에틸에스테르 화합물을 제조한 다음, 환원제인 소디움보로하이드라이드를 사용하여 에스테르화된 부분을 환원시켜 구조식(I)의 2-하이드록시메틸 피리딘 유도체를 제조하는 방법을 개발하고 본 발명을 완성하였다.In the present invention, a compound of formula (VII) is introduced into a compound of formula (VII) to prepare a compound of formula (VIII), and then a nitro group is substituted with a methoxy group to prepare a compound of formula (IX), followed by hydrolysis in a basic aqueous solution. The compound of (X) was prepared and reacted with methanol or ethanol under an acid catalyst to prepare a methyl ester or ethyl ester compound of the pyridine carboxylic acid of formula (XI), followed by esterification using sodium borohydride as a reducing agent. The method for preparing 2-hydroxymethyl pyridine derivative of formula (I) by reducing the oxidized portion was completed and the present invention was completed.
(여기에서, R1과 R2는 각각 수소 또는 메틸기이며, R3는 메틸 또는 에틸기이다).(Wherein R 1 and R 2 are each hydrogen or methyl group and R 3 is methyl or ethyl group).
본 발명의 출발물질인 구조식(VII)의 화합물은 Acta Cryst, B33, 1549-1556(1977)과 독일 공개특허 제2,112,832호 등의 문헌에 기재된 방법에 의하여 제조할 수 있는 것으로, 본 발명에서는 이 화합물을 Reissert-Kaufmann 반응을 이용하여 시안화나트륨 또는 시안화칼륨과 반응시켜 구조식(VIII)의 2-시아노 피리딘 유도체를 얻는다. 이 반응은 촉매 및 반응용매로서 작용하는 디메틸설페이트를 과량 사용하면 시안화합물의 제조수율이 상당히 높아진다. 다음에 나트륨 메톡사이드를 사용하여 니트로기를 메톡시기로 치환시켜 구조식(IX) 화합물은 고수율로 제조하였으며, 나아가 구조식(IX) 화합물의 가수분해 반응은 수용액중에서도 행할 수는 있으나, 황산, 염산등의 산성수용액중에서는 탈탄산반응이 일어나기 쉬우므로 수산화칼륨, 수산화나트륨등의 염기성 수용액에서 반응을 행하여 구조식(X)의 화합물을 제조하였다.The compound of formula (VII), which is the starting material of the present invention, can be prepared by the methods described in Acta Cryst, B33, 1549-1556 (1977) and German Laid-open Patent No. 2,112,832. Is reacted with sodium cyanide or potassium cyanide using the Reissert-Kaufmann reaction to obtain a 2-cyano pyridine derivative of formula (VIII). In this reaction, when the excess amount of dimethyl sulfate serving as a catalyst and a reaction solvent is used, the yield of the cyanide compound is significantly increased. Subsequently, the nitro group was substituted with a methoxy group using sodium methoxide to prepare the compound of formula (IX) in high yield. Furthermore, the hydrolysis reaction of the compound of formula (IX) can be carried out in an aqueous solution. In the acidic aqueous solution, the decarboxylation reaction is likely to occur, so that the reaction was carried out in a basic aqueous solution such as potassium hydroxide and sodium hydroxide to prepare a compound of formula (X).
구조식(X)의 화합물은 황산, 염산 또는 메탄술폰산등의 산촉매하에 메탄올, 에탄올등의 저급알코올과 반응시켜 에스테르 화합물인 구조식(XI) 화합물을 얻은 다음, 이를 소디움보로하이드라이드로 환원시킨다. 구조식(XI)의 화합물의 환원시에 소디움보로하이드라이드를 사용하면, 메탄올등 알콜류의 용매하에 실온에서도 쉽게 환원반응이 일어나며, 수분의 존재하에서도 환원 반응을 행할 수 있으며, 취급도 용이하여 산업에의 이용상에 대단히 중요하다. 그런, 리튬알루미늄하이드라이드를 사용하면 무수상태에서 인화점이 극히 낮은 에테르 용매중에서 행하여야함으로 대단한 주의하에 반응을 행하여야 하고, 반응후에도 미반응의 잔존하는 리튬알루미늄하이드라이드를 분해시켜야 하기 때문에 대량 생산에는 문제가 있다. 그럼으로 환원제로는 소디움보로하이드라이드를 사용함이 바람직하다. 이렇게 반응시켜서 고수율로 구조식(I)의 화합물을 얻을 수 있었으며, 이를 티오닐클로라이드와 독일공개특허 제2,428,294호 및 제3,040,248호에 기재된 방법으로 반응시키면 구조식(XII)의 화합물도 제조할 수 있었다.The compound of formula (X) is reacted with lower alcohols such as methanol and ethanol under an acid catalyst such as sulfuric acid, hydrochloric acid or methanesulfonic acid to obtain an ester compound of formula (XI), which is then reduced to sodium borohydride. When sodium borohydride is used for the reduction of the compound of formula (XI), the reduction reaction occurs easily at room temperature in a solvent of alcohols such as methanol, and the reduction reaction can be carried out even in the presence of moisture. It is very important for use. In the case of using lithium aluminum hydride, the reaction should be carried out with great caution because it should be carried out in an ether solvent having a very low flash point in anhydrous state, and even after mass production, the lithium aluminum hydride must be decomposed. there is a problem. Therefore, sodium borohydride is preferably used as the reducing agent. By reacting in this way, the compound of formula (I) was obtained in high yield, and the reaction of thionyl chloride with the method described in German Patent Publication Nos. 2,428,294 and 3,040,248 could also prepare the compound of formula (XII).
다음 실시예에서 본 발명을 좀더 구체적으로 설명한다.The present invention is explained in more detail in the following examples.
[실시예 1]Example 1
2-시아노-3,5-디메틸-4-니트로피리딘의 제조Preparation of 2-cyano-3,5-dimethyl-4-nitropyridine
디메틸설페이트 250g 에 3,5-디메틸-4-니트로피리딘 N-옥사이드 168g을 첨가하고 2시간동안 환류시킨 후 냉각하여 생성된 고형물을 여과하여 정제수 500ml 에 용해한 다음, 정제수 700ml 에 시안화칼륨 100g을 용해시킨 용액에 0-3℃의 온도를 유지하면서 2시간동안 적가한 후, 생성된 침전물을 여과하여 갈색의 표제화합물 156g을 얻었다.168 g of 3,5-dimethyl-4-nitropyridine N-oxide was added to 250 g of dimethyl sulfate, refluxed for 2 hours, and the resulting solid was filtered and dissolved in 500 ml of purified water. Then, 100 g of potassium cyanide was dissolved in 700 ml of purified water. The solution was added dropwise while maintaining the temperature at 0-3 ° C. for 2 hours, and then the resulting precipitate was filtered to give 156 g of the brown title compound.
융점 : 70-72℃Melting Point: 70-72 ℃
원소분석치 C8H7N3O2 Elemental Analysis C 8 H 7 N 3 O 2
이론치(%) :C;54,24, H;3.98, N;23.72Theoretical (%): C; 54,24, H; 3.98, N; 23.72
실측치(%) :C;53.87, H;3.92, N;24.02Found (%): C; 53.87, H; 3.92, N; 24.02
IR:γKBr cm-1: 2,220, 1,550, 1,370, 1,290, 1,045IR: γKBr cm -1 : 2,220, 1,550, 1,370, 1,290, 1,045
NMR(CDCl3) δ:8.16(s,1H), 2.27(s,3H), 2.17(s,3H)NMR (CDCl 3 ) δ: 8.16 (s, 1H), 2.27 (s, 3H), 2.17 (s, 3H)
[실시예 2]Example 2
2-시아노-3,5-디메틸-4-메톡시 피리딘의 제조Preparation of 2-cyano-3,5-dimethyl-4-methoxy pyridine
반응조에 질소가스를 통과시키면서 나트륨금속 25g을 메탄올 800ml에 용해하고 2-시아노-3,5-디메틸-4-니트로피리딘 177g을 첨가하여 1시간동안 환류시킨 다음, 생성된 침전물을 여과하여 제거하고, 여과액을 감압농축한 후, 잔류액에 에틸 아세테이트 1500ml 와 정제수 500ml을 가하여 30분간 교반하여 에틸 아세테이트층을 분리하고 망초로 수분을 제거한 후 감압으로 용매를 제거하고 잔류물에 메탄올 100ml와 정제수500ml을 가하여 입자화시킨 다음, 냉각하여 2시간동안 교반하여 여과하여 엷은 갈색의 표제화합물 154g을 얻었다.While passing nitrogen gas through the reactor, 25 g of sodium metal was dissolved in 800 ml of methanol, and 177 g of 2-cyano-3,5-dimethyl-4-nitropyridine was added to reflux for 1 hour, and the resulting precipitate was filtered off. The filtrate was concentrated under reduced pressure, 1500 ml of ethyl acetate and 500 ml of purified water were added to the residue, followed by stirring for 30 minutes. The ethyl acetate layer was separated, water was removed with a forget-me-not, and the solvent was removed under reduced pressure. After addition, the mixture was granulated, cooled, stirred for 2 hours, and filtered to obtain 154 g of a pale brown title compound.
융점 : 57-59℃Melting Point: 57-59 ℃
원소분석치 C9H10N2OElemental Analysis C 9 H 10 N 2 O
이론치(%) :C;66.65, H;6.21, N;17.27Theoretical value (%): C; 66.65, H; 6.21, N; 17.27
실측치(%) :C;66.64, H;6.22, N;17.31Found (%): C; 66.64, H; 6.22, N; 17.31
IR:γKBr cm-1: 2,219, 1,560, 1,470, 1,250, 1,080, 865IR: γKBr cm -1 : 2,219, 1,560, 1,470, 1,250, 1,080, 865
NMR(CDCl3) δ:8.16(s,1H), 3.75(s,3H), 2.27(s,3H), 2.18(s,3H)NMR (CDCl 3 ) δ: 8.16 (s, 1H), 3.75 (s, 3H), 2.27 (s, 3H), 2.18 (s, 3H)
[실시예 3]Example 3
(3,5-디메틸-4-메톡시-2-피리딜)카르복실산의 제조Preparation of (3,5-dimethyl-4-methoxy-2-pyridyl) carboxylic acid
20% 수산화나트륨 수용액 500ml 에 2-시아노-3,5-디메틸-4-메톡시피리딘 48g을 가하여 3시간 환류 시킨 후, 진환 황산으로 중화시키고 감압으로 물을 제거한 다음, 잔류물에 메탄올 500ml을 가하고 여과하여 불용물을 제거한 후 여과액을 감압하에 용매를 제거하고 잔류물에 노르말 헥산을 가하여 결정화시킨 후 여과하여 엷은 갈색의 표제화합물 53g을 얻었다.After refluxing for 3 hours by adding 48 g of 2-cyano-3,5-dimethyl-4-methoxypyridine to 500 ml of 20% aqueous sodium hydroxide solution, the mixture was neutralized with cyclic sulfuric acid, water was removed under reduced pressure, and then 500 ml of methanol was added to the residue. After adding to the filtrate to remove the insolubles, the filtrate was removed under reduced pressure, and the residue was crystallized by adding normal hexane to the residue, followed by filtration to obtain 53 g of a pale brown title compound.
융점 : 130-134℃Melting Point: 130-134 ℃
원소분석치 C9H11NO3 Elemental Analysis C 9 H 11 NO 3
이론치(%) :C;59.66, H;6.12, N;7.73Theoretical (%): C; 59.66, H; 6.12, N; 7.73
실측치(%) :C;59.68, H;6.14, N;7.78Found (%): C; 59.68, H; 6.14, N; 7.78
IR:γKBr cm-1: 1,700, 1,570, 1,250, 1,060, 778IR: γKBr cm -1 : 1,700, 1,570, 1,250, 1,060, 778
NMR(d6-DMSO) δ:8.16(s,1H), 3.75(s,3H), 2.27(s,3H), 2.18(s,3H)NMR (d 6 -DMSO) δ: 8.16 (s, 1H), 3.75 (s, 3H), 2.27 (s, 3H), 2.18 (s, 3H)
[실시예 4]Example 4
(3,5-디메틸-4-메톡시-2-피리딜)카르복실산 메틸에스테르의 제조Preparation of (3,5-dimethyl-4-methoxy-2-pyridyl) carboxylic acid methyl ester
무수메탄올 1ℓ에 (3,5-디메틸-4-메톡시-2-피리딜)카르복실산 163g 과 진한황산 18g을 가하고 10시간 환류시킨 후, 감압으로 메탄올을 제거하고 잔류물에 클로로포름 1ℓ을 가하고 포타슘카보네이트 수용액으로 중화한 다음, 클로로포름층을 분리하여 망초로 수분을 완전히 제거하고, 감압으로 용매를 제거하여 시럽상태의 표제화합물 158g을 얻었다.163 g of (3,5-dimethyl-4-methoxy-2-pyridyl) carboxylic acid and 18 g of concentrated sulfuric acid were added to 1 L of anhydrous methanol, and the mixture was refluxed for 10 hours. Then, methanol was removed under reduced pressure, and 1 L of chloroform was added to the residue. After neutralizing with aqueous potassium carbonate solution, the chloroform layer was separated to completely remove water with a forget-me-not, and the solvent was removed under reduced pressure to obtain 158 g of the title compound in a syrup state.
원소분석치 C10H13NO3 Elemental Analysis C 10 H 13 NO 3
이론치(%) :C;61.53, H;6.71, N;7.17Theoretic value (%): C; 61.53, H; 6.71, N; 7.17
실측치(%) :C;61.58, H;6.82, N;7.22Found (%): C; 61.58, H; 6.82, N; 7.22
IR:γKBr cm-1: 2,970, 1,725, 1,565, 1,392, 1,062IR: γKBr cm -1 : 2,970, 1,725, 1,565, 1,392, 1,062
NMR(CDCl3) δ:8.16(s,1H), 3.75(s,3H), 3.55(s,3H), 2.27(s,3H), 2.18(s,3H)NMR (CDCl 3 ) δ: 8.16 (s, 1H), 3.75 (s, 3H), 3.55 (s, 3H), 2.27 (s, 3H), 2.18 (s, 3H)
[실시예 5]Example 5
2-하이드록시메틸-3,5-디메틸-4-메톡시피리딘 염산염의 제조Preparation of 2-hydroxymethyl-3,5-dimethyl-4-methoxypyridine hydrochloride
메탄올 800ml 에 (3,5-디메틸-4-메톡시-2-피리딜)카르복실산 메틸에스테르 97g 과 소디움보로하이드라이드 17g을 첨가하여 실온에서 3시간 교반하고 감압으로 메탄올을 제거한 후 잔류물에 정제수 200ml 와 클로로포름 1ℓ을 가하여 유기층을 분리하고 망초로 수분을 제거한 후 감압으로 용매를 제거하고 잔류물에 메틸에틸케톤 200ml 와 진한염산 50ml을 가하여 냉각시키고 여과하여 비늘상태의 흰색고체인 표제화합물 91g을 얻었다.97 g of (3,5-dimethyl-4-methoxy-2-pyridyl) carboxylic acid methyl ester and 17 g of sodium borohydride were added to 800 ml of methanol, the mixture was stirred at room temperature for 3 hours, and the residue was removed under reduced pressure. 200 ml of purified water and 1 l of chloroform were added to separate an organic layer, and water was removed with a forget-me-not. Then, the solvent was removed under reduced pressure. 200 ml of methyl ethyl ketone and 50 ml of concentrated hydrochloric acid were added to the residue, which was then cooled and filtered to give 91 g of the title compound as a white solid. Got.
융점 : 126-127℃Melting Point: 126-127 ℃
IR:γKBr cm-1: 3,200, 1,608, 1,520, 1,466, 1,200IR: γKBr cm -1 : 3,200, 1,608, 1,520, 1,466, 1,200
NMR(d6-DMSO) δ:8.41(s,1H), 4.65(s,3H), 3.75(s,3H), 2.27(s,3H), 2.18(s,3H)NMR (d 6 -DMSO) δ: 8.41 (s, 1H), 4.65 (s, 3H), 3.75 (s, 3H), 2.27 (s, 3H), 2.18 (s, 3H)
[실시예 6]Example 6
2-클로로메틸-4-메톡시-3,5-디메틸 피리딘의 염산염의 제조Preparation of Hydrochloride of 2-Chloromethyl-4-methoxy-3,5-dimethyl Pyridine
클로로포름 500ml 에 2-하이드록시메틸-4-메톡시-3,5-디메틸피리딘 염산염 102g을 가하고 0-5℃ 냉각시킨 후 티오닐클로라이드 100ml를 20℃ 이하의 온도를 유지하면서 가하고, 20℃에서 3시간 교반한 후, 감압으로 미반응 티오닐 클로라이드를 완전히 제거한다. 잔류물에 클로로포름 250ml를 가하여 여과하고 여과액에 에틸에테르 750ml를 가하여 입자를 생성시키고 냉각시켜 2시간동안 교반하고 여과한 다음, 여과물을 에테르로 세척하고 건조하여 흰색 결정을 표제화합물 106g을 얻었다.102 g of 2-hydroxymethyl-4-methoxy-3,5-dimethylpyridine hydrochloride was added to 500 ml of chloroform and cooled to 0-5 ° C., and then 100 ml of thionyl chloride was added while maintaining the temperature below 20 ° C., and 3 at 20 ° C. After stirring for an hour, unreacted thionyl chloride is completely removed by reduced pressure. 250 ml of chloroform was added to the residue, followed by filtration. 750 ml of ethyl ether was added to the filtrate to form particles, which were cooled, stirred for 2 hours, filtered, and the filtrate was washed with ether and dried to give 106 g of the title compound.
융점 : 128℃Melting Point: 128 ℃
IR:γKBr cm-1: 3,020, 1,785, 1,614, 1,480, 1,310IR: γKBr cm -1 : 3,020, 1,785, 1,614, 1,480, 1,310
NMR(CDCl3+d6-DMSO) δ:8.41(s,1H), 4.65(s,-2H), 3.75(s,3H), 2.27(s,3H), 2.18(s,3H).NMR (CDCl 3 + d 6 -DMSO) δ: 8.41 (s, 1H), 4.65 (s, -2H), 3.75 (s, 3H), 2.27 (s, 3H), 2.18 (s, 3H).
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019880016395A KR910000481B1 (en) | 1988-12-09 | 1988-12-09 | Process for preparing pyridine derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019880016395A KR910000481B1 (en) | 1988-12-09 | 1988-12-09 | Process for preparing pyridine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
KR900009590A KR900009590A (en) | 1990-07-05 |
KR910000481B1 true KR910000481B1 (en) | 1991-01-25 |
Family
ID=19279992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880016395A KR910000481B1 (en) | 1988-12-09 | 1988-12-09 | Process for preparing pyridine derivatives |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR910000481B1 (en) |
-
1988
- 1988-12-09 KR KR1019880016395A patent/KR910000481B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR900009590A (en) | 1990-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111662325B (en) | Method for preparing L-glufosinate-ammonium | |
US2734904A (en) | Xcxnhxc-nh | |
US5239077A (en) | Highly pure amidoximes | |
CA2055378A1 (en) | Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide | |
KR910000481B1 (en) | Process for preparing pyridine derivatives | |
JP2668816B2 (en) | Process for producing benzothiadiazole derivative | |
KR101115576B1 (en) | Method for preparing sulfonium salt and sulfonium salt prepared by the same | |
CN108484495B (en) | Synthetic method of 3-bromo-7-hydroxyquinoline | |
EP0062068B1 (en) | N-phthalidyl-5-fluorouracil derivatives | |
KR920004932B1 (en) | Method of producing for pyridine derivatives | |
KR20070082985A (en) | Preparation method of oseltamivir | |
KR810000481B1 (en) | Process for the preparation of substituted n-(carboxymethyl) 1-3-aminopropane-2-ol | |
JP3357570B2 (en) | Method for producing 3-substituted-1-propanol | |
JPS61178999A (en) | Organogold compound | |
CA1056400A (en) | Process for the preparation of 1,4-naphthodinitrile | |
KR100359256B1 (en) | Improved method of preparing lansoprazole | |
US3381014A (en) | Process for producing pyridoxine and novel intermediates thereof | |
KR920000695B1 (en) | Method of preparation for pyridine derivatives | |
KR820001386B1 (en) | Process for preparation of 5-methyl-4(2-aminoethyl) thio ethyl imidazol | |
US6300503B1 (en) | Hydantoin intermediates for the synthesis of omapatrilat and methods for producing and using the same | |
KR930003757B1 (en) | The producing method of substituted beta phenyl acrylic acid | |
JP2536756B2 (en) | 5-alkoxyanthranilic acid ester | |
JPS5995286A (en) | Imidazo(4,5-c)pyridine-6-carboxylic acid derivative | |
KR790001684B1 (en) | Process for the preparation of 5-benzyl picolinic acids | |
JPS60152469A (en) | Preparation of cis-diester derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
O035 | Opposition [patent]: request for opposition | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20030124 Year of fee payment: 13 |
|
LAPS | Lapse due to unpaid annual fee |